Collegium Pharmaceutical Inc (COLL)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793	306,302	303,978	301,581	294,362
Total stockholders’ equity	US$ in thousands	195,431	178,873	200,805	179,733	194,842	197,194	197,612	196,076	202,928	251,094	253,066	170,035	186,031	172,686	155,767	141,063	87,432	84,258	85,823	86,350
Financial leverage ratio		5.85	6.58	6.05	6.76	6.03	6.09	6.30	6.36	3.41	2.95	2.82	3.80	3.46	3.73	4.15	4.50	3.50	3.61	3.51	3.41

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,143,310K ÷ $195,431K
= 5.85

The financial leverage ratio of Collegium Pharmaceutical Inc has demonstrated fluctuations over the quarters in the period indicated. The ratio, which measures the company's level of debt in relation to equity, varied between Q1 2022 and Q4 2023, ranging from 5.85 to 6.76.

The trend indicates that the company's reliance on debt has been relatively high, with the ratio consistently above 5. This suggests that Collegium Pharmaceutical Inc has been leveraging its capital structure with a significant amount of debt compared to equity over the period analyzed.

It is important to note that a higher financial leverage ratio signifies a higher level of financial risk due to increased debt obligations, which can potentially impact the company's financial stability and ability to meet its financial obligations.

Further analysis and monitoring of the financial leverage ratio trend will be necessary to assess the company's ability to manage its debt effectively and maintain a sustainable capital structure.